Dark

KALA
KALA BIO, Inc. Common Stock
stock NASDAQ

At Close

Sep 29, 2026 3:59:30 PM EDT

0.5055USD+12.283%(+0.0553)10,024,921

0.4200Bid 0.5800Ask 0.1600Spread

Pre-market

Sep 29, 2026 9:28:30 AM EDT

0.4174USD-7.286%(-0.0328)322,806

After-hours

Sep 29, 2026 4:41:30 PM EDT

0.5067USD+0.237%(+0.0012)37,466

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

9.78M

CEO

Mark Iwicki

Headquarters

Watertown, Massachusetts, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Nov 18, 2026 (50d)

Last Split

May 11, 20261for50reverse

OMER XLV

KALA Stats

Avg. Vol. 10 Day

246,830

Avg. Vol. 30 Day

577,373

Employees

Market Cap

9,776,262

Shares Out.

19,339,786

On/Off Exchange

37%/63%

6 Month Beta

2.47

1 Year Beta

2.20

2 Year Beta

1.48

3 Year Beta

1.23

52 Week Low

0.43

52 Week High

123.00

SMA50

0.68

SMA200

10.51

1 Week

-15.61%

1 Month

-26.75%

3 Month

-75.81%

6 Month

-94.09%

1 Year

-99.51%

2 Year

-99.82%

5 Year

-99.99%

Profile

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala's website at www.kalarx.com.

KALA Stock Summary

KALA BIO, Inc. Common Stock (NASDAQ:KALA) stock price today is $0.5055, and today's volume is 10,024,921. KALA is up 12.283% today. The 30 day average volume is 577,373. KALA market cap is 9.78M with 19,339,786 shares outstanding.